Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study

PURPOSE: High-dose chemotherapy with autologous stem cell transplantation (ASCT) is considered to be the only curative treatment option for patients with refractory or relapsed diffuse large B-cell lymphoma (DLBCL). Due to toxicity, not all patients are eligible for this treatment leading to differe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Epidemiol
Egile Nagusiak: Arboe, Bente, Olsen, Maja Halgren, Gørløv, Jette Sønderskov, Duun-Henriksen, Anne Katrine, Dalton, Susanne Oksbjerg, Johansen, Christoffer, de Nully Brown, Peter
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2019
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6407517/
https://ncbi.nlm.nih.gov/pubmed/30881137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S178003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak